Ocugen, Inc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.

About OCGN

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. 

CEO
Shankar Musunuri
CEOShankar Musunuri
Employees
116
Employees116
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
2013
Founded2013
Employees
116
Employees116

OCGN Key Statistics

Market cap
474.75M
Market cap474.75M
Price-Earnings ratio
-5.46
Price-Earnings ratio-5.46
Dividend yield
Dividend yield
Average volume
3.47M
Average volume3.47M
High today
$1.42
High today$1.42
Low today
$1.37
Low today$1.37
Open price
$1.40
Open price$1.40
Volume
2.45M
Volume2.45M
52 Week high
$2.73
52 Week high$2.73
52 Week low
$1.00
52 Week low$1.00

Stock Snapshot

With a market cap of 474.75M, Ocugen, Inc(OCGN) trades at $1.40. The stock has a price-to-earnings ratio of -5.46.

On 2026-08-22, Ocugen, Inc(OCGN) stock moved within a range of $1.37 to $1.42. With shares now at $1.40, the stock is trading +2.2% above its intraday low and -1.4% below the session's peak.

Trading activity shows a volume of 2.45M, compared to an average daily volume of 3.47M.

The stock's 52-week range extends from a low of $1.00 to a high of $2.73.

The stock's 52-week range extends from a low of $1.00 to a high of $2.73.

OCGN News

MarketWatch 2d
Ocugen Inc. stock falls Thursday, underperforms market - MarketWatch

...

Ocugen Inc. stock falls Thursday, underperforms market - MarketWatch
TipRanks 3d
Ocugen’s Phase 3 Gene Therapy Trial Targets High-Value Dry AMD Market

Ocugen Inc (OCGN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident in...

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own OCGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.